Yahoo Web Search

Search results

    • Monitoring Xilio Therapeutics Inc

      Knox Daily· 1 day ago

      Xilio Therapeutics Inc’s recent filing unveils that its 10% Owner GILEAD SCIENCES, INC. acquired Company’s shares for reported $0.37 million on Apr 02 ’ ...

    • Ipsen drug for rare liver disease approved by FDA

      Ipsen drug for rare liver disease approved by FDA

      BioPharma Dive via Yahoo Finance· 11 hours ago

      The medicine will join Intercept’s Ocaliva as a treatment option for primary biliary cholangitis. Another drug, from the now Gilead-owned CymaBay, could...